The research report titled Synthetic Biology: A Global Strategic Business Report announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, drivers, opportunities, challenges and issues in addition to current coverage on company information and latest news and events including strategic corporate developments, and product innovations. The report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.
To view complete report details including the full table of contents (TOC) and to sign up for a comprehensive complimentary review of our research program including details on methodology, secondary and primary sources and summary of research findings, please
By forming alliances with Dentsu Group clients and partner companies, Dentsu Ventures will support Twist Bioscience's innovative business development.
Profiles of Twist Bioscience and Dentsu Ventures are provided below.
Profile of Twist Bioscience
Company Name: Twist Bioscience Corporation
Location: San Francisco, California, U.S.A.
Representative: Emily LeProust (CEO)
Line of Business: Providing High-Throughput DNA Synthesis for Multiple Industries
Profile of Dentsu Ventures
Name: Dentsu Ventures Global Fund I
Total Fund Capital: 10.0 billion yen
Date of Establishment: April 2015
Period of Operation: Slated for 10-year period, through March 2025
Investment Regions: Global investments with a focus on the U.S., Europe Japan and Asia
Investment Stages: Balanced, wide-ranging investments with the focus on seed and early stage investments, but also including mid-stage and later-stage investments
(1) Areas that can change the marketing and communication business in a broad sense
(2) New areas other than the above that have a high potential for innovation
Synthetic Biology Market Trends - Global Industry Analysts, Inc.
HOUSTON, Oct. 16, 2017 (GLOBE NEWSWIRE) — Synthesis Energy Systems, Inc. (SES) (NASDAQ:SYMX), a global leader in the clean and efficient production of low-cost synthesis gas for high value energy and chemical products, today announced that Vice President of Engineering Wade A. Taber will present at the 2017 Syngas Technologies Conference in Colorado Springs, Colorado, on Tuesday, October 17, 11:15 a.m. MT. Mr. Taber will present SES’s Gasification Technology advantages that contribute to high system performance and feed flexibility. Additionally, commercial SES Gasification Technology (SGT) project updates will be discussed, highlighting the excellent operation of SES’s 12th gasifier which, after coming online in April, has been operating successfully for six months.